Analysts: ACADIA Pharmaceuticals Inc (ACAD.O)

ACAD.O on Nasdaq

30.37USD
26 Mar 2015
Change (% chg)

$-0.83 (-2.66%)
Prev Close
$31.20
Open
$30.52
Day's High
$31.24
Day's Low
$29.45
Volume
3,248,179
Avg. Vol
1,963,908
52-wk High
$46.48
52-wk Low
$15.64

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.26 December 26 Mar 2015

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 6 7 5 5
(3) HOLD 0 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.75 1.90 1.88 1.88

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 7 0.09 0.50 0.00 --
Quarter Ending Jun-15 7 0.09 0.50 0.00 --
Year Ending Dec-15 7 7.54 50.10 0.00 11.87
Year Ending Dec-16 8 82.47 200.40 0.00 86.40
Earnings (per share)
Quarter Ending Mar-15 6 -0.26 -0.20 -0.30 --
Quarter Ending Jun-15 6 -0.17 0.38 -0.31 --
Year Ending Dec-15 8 -0.82 -0.13 -1.43 -0.17
Year Ending Dec-16 7 -0.61 0.33 -1.76 -0.04

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-14 0.02 0.05 0.02 96.65
Quarter Ending Sep-14 0.16 0.01 0.14 90.32
Quarter Ending Jun-14 0.26 0.03 0.23 89.17
Quarter Ending Mar-14 0.25 0.03 0.22 88.07
Quarter Ending Dec-13 0.31 0.04 0.27 88.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 0.09 0.09 0.23 0.25 --
Quarter Ending Jun-15 0.09 0.09 0.23 0.25 --
Year Ending Dec-15 7.54 7.54 26.50 33.83 11.87
Year Ending Dec-16 82.47 82.47 142.85 146.84 86.40

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-15 0 0 0 0
Quarter Ending Jun-15 0 0 0 0
Year Ending Dec-15 0 0 0 4
Year Ending Dec-16 0 0 0 6
Earnings

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks